Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Essam Aboelnazar

Essam Aboelnazar

1-General Surgery. 2-Gastrointestinal Surgery with Laparoscopic experience. 3-Hepatobiliary Pancreatic Surgery. 4-Breast Surgery. 5-Thyroid Surgery. 6-Trauma and Emergency Unit (Military Causalities ). 7- Thoracic Surgery.

Title: Prevalence of Venous Thrombo-Embolism & Related Morbidity and Mortality among Hospitalized Patients in Saudi Arabia (SAVTE Study)

Biography

Biography: Essam Aboelnazar

Abstract

This study is a retrospective observational study that was conducted in 7 major hospitals in Kingdom of Saudi Arabia. The primary objectives were to estimate the percentage of patients who received prophylactic thrombolytic treatment according to ACCP guidelines among VTE-patients in addition to, assess the mortality rate in them. The Secondary objectives were: to assess the percentage of VTE confirmed patients in each ward type (surgical and medical), to estimate the percentage of patients prescribed anti-coagulant therapy and adhering to it and to determine percentage of VTE mortality among all cause hospital mortality.

1241 of confirmed VTE were included in the study analysis. 58.3% of them were DVT only, 21.7% were PE and 20% were both DVT and PE.21.4% and 78.6% of confirmed VTE occur in surgical and medical patients respectively. 40.9% of VTE cases received appropriate prophylaxis.

Only 63.2% of surgical patients and 34.8% of medical patients received this prophylaxis (P < 0.001). Mortality rate was 14.3% of all patients representing 1.6% of total hospital mortality. Mortality was 13.5% for surgical patients Vs 14.5% for medical patients (P > 0.05). 89.4% of survived patients received anti-coagulation therapy at discharge and 71.7% of them were adherent to it on follow-up.